Artivion (AORT) officer sells 6,000 shares at $45.73 average

Artivion, Inc. (AORT) reported an insider stock sale by a senior officer.

Rhea-AI Filing Summary

Artivion, Inc. (AORT) reported an insider stock sale by a senior officer. On 11/17/2025, the company’s VP and Chief Accounting Officer sold 6,000 shares of common stock in an open market transaction at a weighted average price of $45.73 per share, with trade prices ranging from $45.605 to $45.91. After this transaction, the officer beneficially owns 135,380 shares of Artivion common stock, held directly. The filing notes that detailed price breakdowns for each trade within the reported range are available upon request.

Insider Trade Summary

Net Seller: 6,000 shares

Net Sell 1 txn

Insider Horton Amy

Role VP, Chief Accounting Officer

Sold 6,000 shs ($274K)

Type	Security	Shares	Price	Value
Sale	Common Stock	6,000	$45.73	$274K

Holdings After Transaction: Common Stock — 135,380 shares (Direct)

Footnotes (1)

1. F1. Reflects weighted average price. Range of prices were between $45.605 to $45.91. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ARTIVION, INC. (AORT) report on this Form 4?

The filing reports that a company officer sold 6,000 shares of ARTIVION, INC. common stock in an open market transaction on 11/17/2025.

At what price were the 6,000 ARTIVION (AORT) shares sold?

The 6,000 shares were sold at a weighted average price of $45.73 per share, with individual trade prices ranging from $45.605 to $45.91.

How many ARTIVION (AORT) shares does the insider own after the sale?

Following the reported transaction, the officer beneficially owns 135,380 shares of ARTIVION, INC. common stock, held directly.

What is the insider’s role at ARTIVION, INC. (AORT)?

The reporting person is an officer of ARTIVION, INC., serving as VP, Chief Accounting Officer.

Does the Form 4 filing for ARTIVION (AORT) include any derivative securities transactions?

The provided content shows no reported transactions in derivative securities in Table II; only a common stock sale is detailed in Table I.

Is detailed trade price information available for the ARTIVION (AORT) insider sale?

Yes. The filing states that the reporting person will provide full information on the number of shares sold at each separate price within the $45.605 to $45.91 range upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/18/2025 - 12:57 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Horton Amy

(Last) (First) (Middle)

ARTIVION, INC.

1655 ROBERTS BLVD, NW

(Street)

KENNESAW GA 30144

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/17/2025		S		6,000	D	$45.73(1)	135,380	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects weighted average price. Range of prices were between $45.605 to $45.91. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Remarks:

	/s/ Amy Horton	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.